baber/WOPTO huggingface dataset:
Patent FI-933893-A0 (FI)
Inventor: GALLAHER DANIEL D
IPC: A23L1/308
Filed: 1993-09-06
Abstract: A method for reducing the cholesterol level in mammalian blood by administering a water soluble cellulose ether thereto. The cellulose ethers have a viscosity, measured as a 2% aqueous solution at 20 DEG C, of at least about 35 cps. Oral administration is preferred, and, in one embodiment the high viscosity water soluble cellulose ether is hydroxypropyl methylcellulose, contained in a nutritious foodstuff.
Patent FI-935463-A0 (FI)
Inventor: FASSBERG JULIANNE
IPC: A61P11/06
Filed: 1993-12-07
Abstract: An aerosol formulation for administration of medicament has 1,1,1,2-tetrafluoroethane as propellant and an excipient which is a propylene glycol diester of a C₆-C₁₂ fatty acid or a triglyceride ester of a C₆-C₁₂ fatty acid.
Patent FI-942811-A0 (FI)
Inventor: AHOKAS MATTI
IPC: D21F5/04
Filed: 1994-06-14
Abstract: The invention concerns a dryer section for a paper machine, comprising at least dryer groups (R) provided with single-wire draw (15), each of which groups comprises a number of drying cylinders (10) and a number of reversing cylinders or rolls (11) in the gaps between the drying cylinders (10), and in each of which dryer groups (R) the web (W) runs under constant contact with the wire (15) over the drying cylinders (10) and reversing cylinders or rolls (11) so that the web (W) enters into direct contact with the drying cylinders (10) and that the wire (15) enters into direct contact with the reversing cylinders or rolls (11). In the groups (R) with single-wire draw in the dryer section, at least four drying cylinders (10) are placed in pairs side by side and one above the other so that the upper pair of cylinders is placed at a lower level than the other cylinders in the group. <IMAGE>
Patent FI-942937-A0 (FI)
Inventor: LO JULIAN B
IPC: A61J3/10
Filed: 1994-06-17
Abstract: PCT No. PCT/US92/09273 Sec. 371 Date Jun. 1, 1994 Sec. 102(e) Date Jun. 1, 1994 PCT Filed Nov. 4, 1992 PCT Pub. No. WO93/12770 PCT Pub. Date Jul. 8, 1993.High strength, high porosity delivery devices have a shaped surface and disintegrate quickly in an aqueous medium. The devices can be prepared by disposing a formulation in a die to form a frozen predevice. A second die is contacted with the frozen formulation surface at a pressure and temperature for a time sufficient to locally momentarily liquify and shape the device surface. The shaping is followed by lyophilization.
Patent FI-951025-A0 (FI)
Inventor: SCHREMMER ULF
IPC: B05B1/34
Filed: 1995-03-06
Abstract: The spray nozzle is built into a pipe conduit of a fire-fighting installation comprises a housing in which a flow body forming a torsion mixt. chamber is incorporated. The flow body (4) at the end opposite to the nozzle opening (9) is located tightly in a bore (10) of the housing and is provided with a conical part (6) extending towards the nozzle opening. To the conical part connects a cylindrical pin (7), which in the nozzle opening forms a ring gap (15). The housing (3) is provided with one or more tangential and radially inclined holes (14).
Patent FI-960660-A0 (FI)
Inventor: MURRER BARRY ANTHONY
IPC: A61P35/00
Filed: 1996-02-14
Abstract: Platinum complexes of formula Ia or Ib <CHEM>  where each A, is a leaving group and may be the same or different, which is suitably halo, especially chloro, hydroxy, carboxylate or together form a bi-dentate carboxylate or sulphate, each B, which may be the same or different, is halo, hydroxy, carboxylate, carbamate or carbonate ester, Z is a substituted amine wherein the substituent sterically hinders access of the Pt atom to a DNA strand of a tumour cell, and X is NH3 or mono- or di-alkyl substituted NH3, are active against cancer cells, and appear to show a unique form of chemical and biological action.
Patent FI-981437-A0 (FI)
Inventor: MULLER GEORGE W
IPC: A61K31/4035
Filed: 1998-06-22
Abstract: 1. Use of a compound of the formula <CHEM> in which:  one of R<1> and R<2> is R<3>-X and the other is hydrogen, nitro, cyano, trifluoromethyl, carbo(lower)alkoxy, acetyl, carbamoyl, acetoxy, carboxy, hydroxy, amino, lower alkyl, alkylamino, lower alkoxy, halo, HF2CO, F3CO or R<3>-X-; R<3> is monocycloalkyl, bicycloalkyl or benzocycloalkyl of up to 18 carbon atoms, tetrahydropyran or tetrahydrofuran; X is a carbon-carbon bond, -CH2-, -O- or -N=; R<5> is (i) o-phenylene, unsubstituted or substituted with 1 or more substituents each selected independently from nitro, cyano, halo, trifluoromethyl, carbo(lower)alkoxy, acetyl, or carbamoyl, unsubstituted or substituted with lower alkyl, acetoxy, carboxy, hydroxy, amino, lower alkylamino, lower acylamino, aminoalkyl, or lower alkoxy; (ii) the vicinally divalent residue of pyridine, pyrrolidine, imidizole, naphthalene, or thiophene, wherein the divalent bonds are on vicinal ring carbon atoms; (iii) a vicinally divalent cycloalkyl or cycloalkenyl of 4-10 carbon atoms, unsubstituted or substituted with one or more substituents each selected independently from the group consisting of nitro, cyano, halo, trifluoromethyl, carbo(lower)alkoxy, acetyl, carbamoyl, acetoxy, carboxy, hydroxy, amino, lower alkylamino, lower alkyl, lower alkoxy, or phenyl; (iv) vinylene di-substituted with lower alkyl; or (v) ethylene, unsubstituted or monosubstituted or disubstituted with lower alkyl; R<6> is -CO-, -CH2- or -CH2CO-; Y is -COZ, -CN, -OR<8>, lower alkyl or aryl, Z is -NH2, -OH, -NHR, -R<9>, or -OR<9>; R<8> is hydrogen or lower alkyl; R<9> is lower alkyl or benzyl, and n has a value of 0, 1, 2, or 3,  wherein the term "lower" denotes from 1 to 6 carbon atoms, for the manufacture of a medicament for treating cancer.
Patent FI-991032-A0 (FI)
Inventor: LAINE SAKARI
IPC: H01F27/02
Filed: 1999-05-05
Abstract: The invention relates to a transformer tank generally shaped like a rectangular prism and filled with insulating liquid and assembled mainly by welding. The tank comprises a detachably fastened transformer cover plate and a transformer core placed in the transformer tank while the cover plate is detached. In accordance with the invention, at least one of the substantially vertical walls of the transformer tank comprises a detachable wall portion whose detachment allows the transformer core to be removed from the transformer tank through an opening formed by the detachment of the wall portion. In this way the transformer can be repaired on site without having to lift the transformer core from the transformer tank in the conventional manner, which would require free space above the transformer.
Patent AP-9801239-A0 (AP)
Title: Tetrazoles.
Inventor: MAW GRAHAM NIGEL
Filed: 1998-05-14
Abstract: Tetrazoles and their pharmaceutically acceptable salts which are selective agonists for the delta opioid receptor, particularly usefulin the treatment of inflammatory diseases such as arthritis, psoriasis, asthma,inflammatory bowel disease, disorders of respiratory function,gastro-intestinal disorders such as functional bowel disease and functional g1 disorders of the formula:- wherein r1 is h, c2-c6 alkanoyl, c1-c6 alkenyl, c2-c6 alkynyl, c3-c7 cycloalkyl, (c3-c7 cycloalkyl)-(c1-c4alkyl), (c1-c4 alkoxy)-(c1-c4 alkyl), carboxy-(c1-c4 alkyl), aryl-(c1-c4 alkyl)or heteoaryl-(c1-c4 alkyl); r2 and r3 are each independently h or c1-c4 alkyl; r4 is selected from (i)h, (ii)agroup of the formula r6-9ch2)m-z-(ch2)n-, where m is 0, 1,2 or 3, n is 1,2 or 3, z is a direct link or o , and r6 is -ch2h or -co2(c1-c4 alkyl), and (iii)a group of the formula where r7 is h or c1-c4 alkyl; and r5 is hydroxy, c1-c4 alkoxy or -nhso2(c1-c4 alkyl); with the proviso that when z is o, m is 1,2 or 3 and n is 2 or 3.
Patent IL-90395-A0 (IL)
Title: Gastric retention system for controlled drug release
IPC: A61M31/00
Filed: 1989-05-24
Abstract: An oral drug delivery system having delayed gastrointestinal transit comprising a non-continuous compressible element and an attached controlled release device and which in the expanded form resists gastrointestinal transit; and a modular system for use therein comprising a non-continuous compressible element and an attached receptacle means for receiving and holding a drug-containing orally administrable controlled release device and which in the expanded form resists gastric transit.
Patent IL-95971-A0 (IL)
Title: Erythropoietin isoforms
IPC: C12N15/09
Filed: 1990-10-12
Abstract: Continuation in part of U.S. application no. 421,444 filed 13 October 1989. Erythropoietin isoforms claimed are produced by expression of exogenous DNA in a non-human eukaryotic host cell. They contain amino acids 1-165 or 1-166 of natural human erythropoietin. The isoforms pref. contain 1-14 sialic acid gps. (esp. 9-14 gps.) per erythropoietin molecule. Use of the isoforms and their mixts. are also claimed comprising subjecting a purified erythropoietin to isoelectric focussing and eluting a single isoform from the gel. Specifically claimed erythropoietin analogues are (Asn69) EPO,(Asn125,Ser127) EPO,(Thr125) EPO and (Pro124,Thr125) EPO.
Patent IL-96371-A0 (IL)
Title: Process and intermediates for the preparation of heteroaryl piperidine carbinols
IPC: C07D405/04
Filed: 1990-11-16
Abstract: This invention relates to new compounds of formulae (I, II) in which X is O, S, or NR where R is H or C1-4-alkyl, Z is hydrogen, halogen, trifluoromethyl, C1-8-alkoxy, C1-8-alkyl straight or branched, nitro, C2-8-alkenyl, or a C1-4-alkyl mono- or disubstituted amino group, R<1> is H or straight or branched C1-8-alkyl. The invention also relates to a method of preparing a compound of formulae (I and II).
Patent IL-96730-A0 (IL)
Title: 2-formylbenzylphosphonic acid derivatives,their preparation and their use for the treatment of diseases caused by viruses
IPC: A61K31/675
Filed: 1990-12-19
Abstract: The compound of the formula I <IMAGE> in which R represents an aldehyde group or a group which can be converted into an aldehyde, R<1> and R<2> represent alkyl, alkenyl, alkynyl, aralkyl, cycloalkyl, hydrogen, sodium, potassium, calcium, magnesium, aluminium, lithium, ammonium or triethylammonium or  R<1> and R<2> together form a cyclic diester, R<3> and R<4> represent alkyl, alkenyl, alkynyl, cycloalkyl, hydrogen, alkoxy or halogen, R<5> and R<8> represent alkyl, alkenyl, alkynyl, aralkyl, cycloalkyl, alkoxy, phenyl, cyanide, hydroxyl or hydrogen, X, Y or Z represent oxygen or sulphur, or prodrug forms of the compound of the formula I can be used for treatment of diseases caused by viruses. The preparation of these compounds and pharmaceutical preparations which contain them and also their use are described.
Patent AU-PN015794-A0 (AU)
Title: Variants of human papilloma virus antigens
IPC: C12R1/19
Filed: 1994-12-20
Abstract: Variants of human papilloma virus (HPV) E6 and E7 proteins able to elicit a humoral and/or cellular immune response against HPV in a host animal but not being cell-transforming in the host animal are disclosed, and are useful in treatment or prevention of diseases or conditions involving HPV.
Patent FI-20000113-A0 (FI)
Inventor: EROMAEKI PENTTI
IPC: B60C11/24
Filed: 2000-01-20
Abstract: The present invention relates to a wear indicator for a vehicle tyre (1), the tread of said tyre being provided with grooves (2) to improve the grip. As taught by the invention, the surface of the tread in contact with the road surface is provided with indicators (5) indicating the momentary groove depth (H) of the tyre, said indicators forming at least one group of elements and extending in radial direction into the tyre. The element depth grows by predetermined steps from the shortest element to the longest element. The indicator is formed from a sipe(5) the depth of which is advantageously smaller than the depth (H) of said groove and the cross-section of which in the direction of the tread forms a number, letter, sign or symbol, image or equivalent determining the groove depth of the tread on the height of the plane in the direction of the tread which is tangential to the bottom (2p) of the capillary groove. <IMAGE>
Patent FI-20031647-A0 (FI)
Inventor: KATTAINEN ARI
IPC: B66B1/36
Filed: 2003-11-12
Abstract: A control circuit for controlling an electromechanical elevator brake is disclosed. The control circuit includes at least one brake coil (L1), a direct-voltage source (BR1), a semiconductor switch arrangement, a current measuring unit, at least two semiconductor switches, and a control unit (CO1) for controlling operation of the circuit. The current measuring unit (Lm1) produces current data that is passed to the control unit (CO1). The at least two semiconductor switches (SW1, SW2) are controlled by the control unit (CO1) such that operation is alternated between the two so that the working condition of each switch can be checked in its turn on the basis of feedback data obtained from the current measuring unit.
Patent FI-20075676-A0 (FI)
Inventor: MAIJALA JUHA
IPC: B22F1/054
Filed: 2007-09-28
Abstract: Metal nanoparticles and methods for the production thereof. The novel nanoparticles having an average particle size of 1 to 10 nm and comprising at least one protective group bonded to metal, in particular copper particles, said group being derived from a monomeric thiol. They can be produced by reducing, in the presence of a reducing agent, dithioester monomers to the corresponding thiols while simultaneously reducing a copper precursor to the corresponding metal to yield amorphous or nanocrystalline copper nanoparticles. The novel metal nanoparticles can be used for producing semiconductive or conductive thin layers on a substrate.
Patent FI-20090430-A0 (FI)
Inventor: PIRHONEN JUSSIPERTTI
IPC: H04L67/1095
Filed: 2009-11-16
Abstract: The invention relates to a method for sending data elements between mobile stations (2, 3, 7a, 7b). A pre-determined content, i.e., a transmission information element (1) contains elements and is organized in a manner that allows programs to be transferred from a device to another so that information of the transfer may be registered with a separate database (904). The registration takes place when a receiving device is in communication with a server (4) of a content and/or service provider. Since the method stores the data of all those participating in the transfers, it allows transfer information stored in the data base (904) to be used for rewarding, for example.
Patent IL-100109-A0 (IL)
Title: Apparatus and technique for nmr diffusion measurement
IPC: G01R33/44
Filed: 1991-11-20
Abstract: A method for conducting borehole NMR measurements comprising the steps of: providing a magnetic field and a magnetic field gradient at a desired location along a borehole; carrying out at least one NMR experiment in the presence of the magnetic field gradient; sensing the diffusion effect on the decay of at least the first echo; and     determining therefrom the diffusion coefficient. Apparatus for carrying out the method is also described. <IMAGE>
Patent IL-101871-A0 (IL)
Title: Composition and method of treating depigmentation disorders
IPC: A61K38/44
Filed: 1992-05-14
Abstract: PCT No. PCT/GB92/00878 Sec. 371 Date Nov. 15, 1993 Sec. 102(e) Date Nov. 15, 1993 PCT Filed May 15, 1992 PCT Pub. No. WO92/20354 PCT Pub. Date Nov. 26, 1992.Vitiligo and other tyrosinase-positive depigmentation disorders are treated by topical application of a pseudocatalase and subsequent exposure to a sub-minimal erythema dose of UVB light. After a course of treatment, pigmentation of the affected areas can be maintained by treatment with the pseudocatalases without UVB light treatment. The preferred pseudocatalases are transition metal co-ordination complexes, especially manganese (II) bicarbonate.
Patent IL-102772-A0 (IL)
Title: 3,5-di-tert.-butyl-4-hydroxyphenyl derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
IPC: C07D233/54
Filed: 1992-08-10
Abstract: Compounds of the formula I <IMAGE>  in which   A represents a valency, or a straight or a branched alkyl chain having 1 to 5 C atoms, X represents an -NR-CO- (amide) or an -NR-CO-NR- (urea) group, in which R represents a hydrogen atom or a C1-C4-alkyl radical,  and Y represents a straight-chain or branched, saturated or unsaturated hydrocarbon chain having 1 to 6 C atoms, which can be substituted by an aryl, hetaryl, aryloxy or arylthio radical, a C3-C6-cycloalkyl radical or an aryl radical, where the aryl or hetaryl radical concerned can each be substituted 1 to 3 times in all possible positions on the ring by CN, hydroxymethyl, methylenedioxy, halogen, trifluoromethyl, C1-C4-alkyl, amino, C1-C4-acylamino, di-(C1-C4)-alkylamino, hydroxyl, C1-C4-alkoxy, carboxyl, ethyl oxyacetate or nitro, with the proviso that Y only denotes unsubstituted phenyl if A has a meaning other than -CH2- or -CH2-CH2-, and their pharmacologically acceptable salts, a process for their preparation and pharmaceutical compositions which contain these compounds, for the treatment of metabolic disorders.
Patent IL-109180-A0 (IL)
Title: Improvements in or relating to separators
IPC: C12M1/00
Filed: 1994-03-31
Abstract: PCT No. PCT/GB94/00702 Sec. 371 Date Sep. 26, 1995 Sec. 102(e) Date Sep. 26, 1995 PCT Filed Mar. 31, 1994 PCT Pub. No. WO94/22582 PCT Pub. Date Oct. 13, 1994The invention relates to a separator, which is particularly useful for separating cellular matter. The separator utilizes the phenomenon known as dielectrophoresis (DEP). A DEP force effects a particle suspended in a medium. The particle experiences a force in an alternating electric field. The force is proportional to, amongst other things, the electrical properties of the supporting medium and the particle and the frequency of the electric field. The separator, of the present invention, comprises a chamber (10) and a plurality of electrodes (12) disposed in the chamber (10). An electric field established across electrodes subjects some of the particles to a stronger force than others such that they are confined within the chamber. Particles which are not confined are removed from the chamber by the supporting medium which is preferably urged through the chamber. Valves (101 and 202) are provided on exhausts of the chamber. The invention is able to separate two different particles continuously.
Patent IL-119266-A0 (IL)
Title: Urea derivatives pharmaceutical compositions containing the same and methods of preparation thereof
IPC: C07C317/46
Filed: 1996-09-18
Abstract: Compounds of formula (I): <CHEM> wherein: R<1> is alkyl; R<2a>, R<2b>, R<2c> and R<2d> are the same or different and each is hydrogen, optionally substituted alkyl or various other organic groups; R<3> is alkyl; R<4> is a group of formula (II), (III), (IV), (V), (VI), (VII), (VIII) or (IX): <CHEM> wherein: A<1> is a single bond, alkylene or alkenylene; A<2> is or alkenylene; A<3> is a single bond, alkyleneor alkenylene; R<5a> and R<5b> are the same or different and each is hydrogen, alkyl or various other groups; R<6> is alkyl or phenyl; R<7> is hydrogen or alkyl; R<8> is alkyl or various other groups; and n is 0 or 1Ü and pharmaceutically acceptable salts thereof have valuable inhibitory activity against acyl-CoA: cholesterol acyl transferase.
Patent IL-123468-A0 (IL)
Title: Methods for the preparation of nanosized material particles
IPC: B01J13/00
Filed: 1998-02-26
Abstract: The present invention relates to a method for the production of particles of nano-materials being transition metals and alloys; metal oxides; and ceramic compositions having a small nanosize, i.e. about 1-6 nm. The method comprises a synthesis in the solutions of complex liquids from suitable precursors, which precursors are selected from suitable surfactants and alkoxides, by a suitable chemical reaction under mild conditions; and preparing from said materials fine colloids dispersed in various polymer solutions. The water in the solution is preferably non freezing water, the mild conditions are atmospheric pressure and a temperature range of room temperature to 70° C., and the reaction condition is selected among a hydrolysis, reduction and exchange process.
Patent IL-128928-A0 (IL)
Title: Tricyclic inhibitors of farnesyl protein transferase
IPC: C07D413/14
Filed: 1997-09-11
Abstract: Novel compounds of formula (1.0) are disclosed. Compounds of formula (1.0) are represented by the compounds of formulas (1.4) or (1.5) wherein R<1>, R<3> and R<4> are each independently selected from halo. Also disclosed are methods of inhibiting farnesyl protein transferase and the growth of abnormal cells, such as tumor cells.
Patent IL-137614-A0 (IL)
Title: An inhibitor of a costimulatory pathway and hematopoietic stem cells for promoting graft acceptance
IPC: A61P37/06
Filed: 1999-02-04
Abstract: Use of blockade of costimulation and hematopoietic stem cell transplantation in the promotion of graft acceptance.
Patent IL-153872-A0 (IL)
Title: Getter support assembly for a solar energy collector system
IPC: F24J2/46
Filed: 2003-01-09
Abstract: A getter support assembly for supporting getters in a focusing collector type solar collector system comprising a tube radiation absorber (TRA) and a glass enclosure tube, defining therebetween an annular space, and a solar radiation focusing reflector. The getter support assembly comprises a bridge formed with an elongated trough having a getter support portion. The bridge further comprising feet fixedly attached to the TRA supporting the trough so that the trough is spaced apart from the TRA. The trough further comprises a radiation reflecting surface facing the TRA for blocking radiation emitted from the TRA and missed solar radiation reflected from the reflector.
Patent IL-162051-A0 (IL)
Title: Observation and/or firing system
IPC: F41A23/20
Filed: 2002-09-25
Abstract: The observation and firing system is held on a military vehicle (1). The vehicle has an elevation unit (3) and an observation unit (4). The elevation unit has an interface (19) so that the observation unit can interface to a vehicle holding structure or the elevation unit.
Patent IL-165007-A0 (IL)
Title: Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
IPC: A61P13/12
Filed: 2004-11-03
Abstract: The present invention relates to isolated and/or purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase (DHS) nucleic acids and polypeptides. The present invention also relates to methods of modulating apoptosis using apoptosis-specific eIF-5A and DHS, and antisense oligonucleotides and expression vectors of apoptosis-specific and DHS useful in such methods.
Patent IL-165621-A0 (IL)
Title: Cutting tool and cutting insert therefor
Filed: 2004-12-07
Abstract: A cutting tool in which a cutting insert is retained by a retaining screw. The cutting insert comprises a rear surface and a lower surface, both of which are generally V-shaped.
Patent IL-166388-A0 (IL)
Title: Sliding bearings for the building industry and material for them
IPC: F16C33/20
Filed: 2005-01-19
Abstract: Use of ultra high molecular weight polyethylene (UHMWPE) as material for slide bearings, especially in bridges, is new. An independent claim is included for a slide bearing for industrial use, especially for bridges with high speed sections, which contains UHMWPE and exceeds EN1337/part 2.
Patent IL-172518-A0 (IL)
Title: System and method for configuring voice readers using semantic analysis
IPC: G10L13/08
Filed: 2005-12-12
Abstract: A system and method for using semantic analysis to configure a voice reader is presented. A text file includes a plurality of text blocks, such as paragraphs. Processing performs semantic analysis on each text block in order to match the text block's semantic content with a semantic identifier. Once processing matches a semantic identifier with the text block, processing retrieves voice attributes that correspond to the semantic identifier (i.e. pitch value, loudness value, and pace value) and provides the voice attributes to a voice reader. The voice reader uses the text block to produce a synthesized voice signal with properties that correspond to the voice attributes. The text block may include semantic tags whereby processing performs latent semantic indexing on the semantic tags in order to match semantic identifiers to the semantic tags.